For years, obesity was often seen as a result of poor lifestyle choices. However, experts now suggest that biological factors play a significant role. Some individuals may have a hormonal imbalance ...

Josh Gad has opened up for the first time about using GLP-1 medication for weight loss and ... bulging pouches in the wall of the large intestine" that can cause severe pain, fever, nausea and ...

Background: Despite their potential, Glucagon-like peptide-1 receptor agonists (GLP-1 RA) have not been well studied in cardiac amyloidosis (CA) as randomized trials on GLP-1 RA have excluded patients ...

Josh Gad is opening up about the weight loss success he’s had with GLP-1 medication — and sharing some of the conflicted feelings he’s had along the way. “I’m on a GLP-1 … this is the ...

Copyright: © 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

Further experiments revealed that diabetic mice lacking an intestinal protein called ... sugar metabolism because it stimulates the secretion of GLP-1, which increases circulating insulin, as ...

In a meta-analysis of nine randomized controlled trials, adults had an average lean mass loss of 2.5 kg with GLP-1 therapy. More research is needed to examine the implications of lean mass loss ...

The risks for disease progression and death were lower for patients with stage 3b or higher CKD receiving GLP-1 RA vs DPP4i. Real-world data show that treatment with glucagon-like peptide-1 ...

Although studies have shown that dietary fiber can increase GLP-1 secretion, it’s unclear whether these supplements provide an advantage over a fiber-rich diet with fruits, vegetables, and whole ...

Glucagon-like peptide 1 receptor agonist use was not associated with an increased risk for thyroid cancer compared with use of dipeptidyl peptidase-4 inhibitors. HealthDay News — Glucagon-like peptide ...

New research, with the caveat of a relatively short follow-up, adds to encouraging data showing an overall low risk of the development of thyroid cancer associated with glucagon-like peptide 1 ...

Of those, over 215,000 had been prescribed a glucagon-like peptide-1 (GLP-1) agonist receptor — the class of drugs that includes Ozempic, Wegovy, Mounjaro, Zepbound, and others — and 1.7 ...